Latest MarkLogic releases provide a smarter, simpler, and more secure way to integrate data.
Latest MarkLogic releases provide a smarter, simpler, and more secure way to integrate data.
Join us in Chicago for the biggest global gathering of MarkLogic users and enthusiasts sharing insights on how to Integrate to Innovate.
Join us in Chicago for the biggest global gathering of MarkLogic users and enthusiasts sharing insights on how to Integrate to Innovate.
Be the first to know! News, product information, and events delivered straight to your inbox.
It can take up to 10 years to bring a drug to market, and agility and efficient collaboration are key to the process. AbbVie is leveraging MarkLogic on AWS to help employees discover, share and leverage data to speed collaboration, improve efficiencies, and reduce the costs and time-to-market of creating and delivering new life-saving drugs.
We couldn’t do this with other technologies. We’re delivering these capabilities to our customers in ways that are wickedly performant.”
AbbVie holds extensive knowledge but that information lived in silos, making it difficult to access for scientists, analysts, marketers and more. Additionally, existing collaboration tools were limited in terms of functionality. AbbVie is resolving both of these challenges with MarkLogic and AWS.
In addition to powerful performance and agility, AbbVie is leveraging numerous features in MarkLogic, including full content search, keyword indexing and filtering, fast content ingestion and integration, and fine-grained access control.
AbbVie cut IT project capital costs by $5M in one year.
“MarkLogic serves this information up just in absolute stunning real-time with really high speeds,” said Derek.
“We are doing 10x more than we used to be able to do,” said Phil Hajduk, Vice President, AbbVie
Be the first to know! News, product information, and events delivered straight to your inbox.
By continuing to use this website you are giving consent to cookies being used in accordance with the MarkLogic Privacy Statement.
